Treatment-resistant depression — commonly defined as major depressive disorder that has not improved after at least two adequate treatment trials — affects an estimated one in three people receiving medication treatment for major depressive disorder. For those living in Waite Park and the broader St. Cloud metro area, that can mean years of trying medication after medication without the improvement they hoped for. At Aurora Mental Health & Wellness, we work with patients who have reached that wall, and we want to be clear: a medication failure is not a personal failure, and it is not the end of the road.
Understanding Treatment-Resistant Depression
Depression that resists antidepressant treatment does not mean your depression is untreatable. It can mean a careful re-evaluation is needed. Research into treatment-resistant depression includes the roles of multiple brain circuits and neurotransmitter systems, including glutamate, but no single biological explanation applies to every patient. Understanding that complexity can help guide what comes next.
At Aurora Mental Health & Wellness in Waite Park, we begin every new patient conversation with a thoroughpsychiatric evaluation. Before we discuss advanced treatments, we want to understand whether previous medication trials were completed at therapeutic doses for adequate durations, whether co-occurring conditions have been properly identified, and whether other relevant contributors may need attention. Emily Luitjens, FNP-BC, PMHNP-BC, brings more than 10 years of experience from VA medical centers, where she worked with complex and treatment-resistant presentations. That clinical precision guides the work we do here.
When an evaluation supports a treatment-resistant depression diagnosis, we can discuss options that work differently from conventional antidepressants.
IV Ketamine for Treatment-Resistant Depression
IV ketamine is an off-label psychiatric treatment that acts, in part, through the NMDA glutamate receptor system. Studies have reported rapid antidepressant effects for some adults with treatment-resistant depression, although response and timing vary by individual.
Because IV ketamine may work differently than standard oral antidepressants, it can be an option to discuss when conventional medication approaches have not provided adequate relief. Psychiatric uses of IV ketamine are off-label, meaning the FDA has not specifically approved ketamine for depression. We evaluate each patient carefully before determining whether IV ketamine may be appropriate.
SPRAVATO® for Treatment-Resistant Depression
SPRAVATO® (esketamine) is distinct from IV ketamine and is FDA-approved for treatment-resistant depression in adults. It is administered as a nasal spray in a certified healthcare setting under direct medical supervision.
SPRAVATO® is available only through a Risk Evaluation and Mitigation Strategy program. Patients must be monitored for at least two hours after each treatment session before leaving the healthcare setting. At Aurora Mental Health & Wellness, we discuss whether SPRAVATO® may fit your diagnosis, treatment history, individual needs, and coverage considerations.
TMS Therapy for Depression
TMS Therapy — transcranial magnetic stimulation — is an FDA-cleared, noninvasive treatment that uses targeted magnetic pulses to stimulate brain regions involved in depression. It does not require anesthesia and is completed while patients remain awake.
For adults with major depressive disorder who have not received satisfactory improvement from prior antidepressant medication during the current episode, TMS may be an option to consider. It works differently from medication, but candidacy and expected outcomes should always be discussed through an individual evaluation.
Addressing Financial and Emotional Barriers
We understand that reaching our Waite Park clinic can involve real barriers. One of the most common concerns we hear is financial: will any of this be covered? Coverage varies by treatment, carrier, plan, diagnosis, and authorization requirements. We encourage patients not to assume that cost is prohibitive before we have had a chance to review their individual circumstances and discuss availablefinancing options.
The second barrier we encounter is the sense of defeat that can follow multiple medication failures. Many patients arrive at our clinic having been told — or having told themselves — that they have run out of options. Previous medication failures do not, by themselves, determine whether another approach may be appropriate. Results vary by individual, and we never promise outcomes, but we do promise a thorough, personalized evaluation and a care plan built around your history and clinical needs.
If your depression has not responded to antidepressants and you live in the St. Cloud metro area, we encourage you to discuss these options with our team. An evaluation is the best way to determine which path makes sense for you.
Frequently Asked Questions
What qualifies as treatment-resistant depression?
Treatment-resistant depression is commonly defined as major depressive disorder that has not responded adequately to at least two antidepressant treatments of sufficient dose and duration. Definitions can vary, and a specialist evaluation can clarify whether treatment-resistant depression is the right diagnosis and what options may be appropriate.
Is SPRAVATO® covered by insurance in Minnesota?
Coverage for SPRAVATO® varies by insurance carrier, plan, diagnosis, and authorization requirements. Because SPRAVATO® is FDA-approved for treatment-resistant depression in adults, some plans may provide coverage, but eligibility must be verified individually. We review coverage considerations before treatment begins.
How quickly does IV ketamine work for depression?
Research has found that some patients experience rapid changes in depressive symptoms after IV ketamine treatment. However, individual response and timing vary, and some patients may require more than one infusion before determining whether treatment is helpful. IV ketamine for psychiatric conditions is an off-label use.
Can I try TMS Therapy if I have already failed medications?
TMS Therapy is FDA-cleared for major depressive disorder in adults who have not received satisfactory improvement from prior antidepressant medication during the current episode. Not every patient is a candidate, but our team can discuss whether TMS may be appropriate during an evaluation.
What is the first step at Aurora Mental Health & Wellness in Waite Park?
The first step is a comprehensive psychiatric evaluation. During that appointment, we review your treatment history, confirm relevant diagnoses, consider contributing factors, and discuss available options in detail. You cancontact our Waite Park team to schedule an evaluation.
Key Takeaways
Treatment-resistant depression commonly refers to major depressive disorder that has not improved after at least two adequate treatment trials.
At Aurora Mental Health & Wellness in Waite Park, we offer IV ketamine, SPRAVATO®, and TMS Therapy as options that may be considered after a careful psychiatric evaluation.
IV ketamine is off-label for psychiatric use.
SPRAVATO® is FDA-approved for treatment-resistant depression in adults and requires supervised administration and monitoring through a REMS program.
TMS Therapy is FDA-cleared for major depressive disorder and may be considered for adults whose current episode has not improved with prior antidepressant medication.
Results vary by individual. A personalized psychiatric evaluation is the best way to determine which option fits your history and goals.
Conclusion
Depression that has not responded to medication can be one of the most isolating experiences a person can face. When the treatments that help others have not helped you, the path forward can feel unclear. At Aurora Mental Health & Wellness, we work with patients who have already tried standard options and need a careful, individualized discussion about what comes next.
Whether that involves IV ketamine, SPRAVATO®, TMS Therapy, medication management, or another approach developed through psychiatric evaluation, we will work with you to find a direction that fits your specific clinical picture. Discuss your options with your provider, then reach out to us to schedule your consultation.
About Emily Luitjens
Emily Luitjens, FNP-BC, PMHNP-BC, is the lead provider at Aurora Mental Health & Wellness in Waite Park, Minnesota. She brings more than 10 years of experience from VA medical centers, where she worked with complex presentations involving both physical and psychological symptoms. Her dual training as a family nurse practitioner and psychiatric mental health nurse practitioner gives our team a comprehensive clinical lens for evaluating depression, anxiety, PTSD, and other complex mental-health concerns. At Aurora Mental Health & Wellness, we offer medication management, psychiatry services, and individualized care plans grounded in careful clinical evaluation.
Works Cited
1. Gaynes, B. N., Lux, L., Gartlehner, G., et al. (2020).. Depression and Anxiety, 37(2), 134–145. https://pubmed.ncbi.nlm.nih.gov/31638723/
2. Seshadri, A., Prokop, L. J., & Singh, B. (2024).. Journal of Affective Disorders, 356, 379–384. https://pubmed.ncbi.nlm.nih.gov/38537759/
3. U.S. Food and Drug Administration. (2025).. https://www.accessdata.fda.gov/drugsatfda_docs/label/2025/211243s019lbl.pdf
4. U.S. Food and Drug Administration. (2024).. https://www.accessdata.fda.gov/cdrh_docs/pdf23/K231926.pdf
5. Zhdanava, M., Pilon, D., Ghelerter, I., et al. (2021).. The Journal of Clinical Psychiatry, 82(2), 20m13699. https://www.psychiatrist.com/jcp/prevalence-national-burden-treatment-resistant-depression-major-depressive-disorder-in-us/
Disclaimer
This article is for educational purposes only and is not a substitute for individualized evaluation, diagnosis, or treatment from a qualified healthcare professional.